200 related articles for article (PubMed ID: 9546786)
21. Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells.
Aschkenazi S; Straszewski S; Verwer KM; Foellmer H; Rutherford T; Mor G
Biol Reprod; 2002 Jun; 66(6):1853-61. PubMed ID: 12021072
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of tumor necrosis factor alpha-mediated NFkappaB activation and leukocyte adhesion, with enhanced endothelial apoptosis, by G protein-linked receptor (TP) ligands.
Ashton AW; Ware GM; Kaul DK; Ware JA
J Biol Chem; 2003 Apr; 278(14):11858-66. PubMed ID: 12517920
[TBL] [Abstract][Full Text] [Related]
23. A critical role for TNFalpha in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles.
Mateo T; Naim Abu Nabah Y; Losada M; Estellés R; Company C; Bedrina B; Cerdá-Nicolás JM; Poole S; Jose PJ; Cortijo J; Morcillo EJ; Sanz MJ
Blood; 2007 Sep; 110(6):1895-902. PubMed ID: 17595330
[TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor-mediated, nitric oxide-dependent modulation of the immunologic barrier function of the endothelium: regulation of fas ligand expression by estradiol.
Amant C; Holm P; Xu Sh SH; Tritman N; Kearney M; Losordo DW
Circulation; 2001 Nov; 104(21):2576-81. PubMed ID: 11714653
[TBL] [Abstract][Full Text] [Related]
25. Fas ligand overexpression on allograft endothelium inhibits inflammatory cell infiltration and transplant-associated intimal hyperplasia.
Sata M; Luo Z; Walsh K
J Immunol; 2001 Jun; 166(11):6964-71. PubMed ID: 11359858
[TBL] [Abstract][Full Text] [Related]
26. Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions.
Morigi M; Micheletti G; Figliuzzi M; Imberti B; Karmali MA; Remuzzi A; Remuzzi G; Zoja C
Blood; 1995 Dec; 86(12):4553-8. PubMed ID: 8541545
[TBL] [Abstract][Full Text] [Related]
27. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response.
Sata M; Perlman H; Muruve DA; Silver M; Ikebe M; Libermann TA; Oettgen P; Walsh K
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1213-7. PubMed ID: 9448311
[TBL] [Abstract][Full Text] [Related]
28. Dissociation of Fas-mediated cytotoxicity and FasL expression in a cytotoxic CD4+ T-cell clone. Comparative analysis of Fas-mediated cytotoxicity between a T-hybridoma and a T-cell clone.
Kaneda R; Iwabuchi K; Onoé K
Immunol Lett; 1997 Jan; 55(1):53-60. PubMed ID: 9093882
[TBL] [Abstract][Full Text] [Related]
29. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines.
Arnold R; Seifert M; Asadullah K; Volk HD
J Immunol; 1999 Jun; 162(12):7140-7. PubMed ID: 10358159
[TBL] [Abstract][Full Text] [Related]
30. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
[TBL] [Abstract][Full Text] [Related]
31. Cytokine-induced E-selectin expression by human umbilical vein endothelial cells (HUVEC). A role for protein tyrosine kinases?
May MJ; Wheeler-Jones CP; Pearson JD
Biochem Soc Trans; 1995 May; 23(2):182S. PubMed ID: 7545600
[No Abstract] [Full Text] [Related]
32. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor.
Volpert OV; Zaichuk T; Zhou W; Reiher F; Ferguson TA; Stuart PM; Amin M; Bouck NP
Nat Med; 2002 Apr; 8(4):349-57. PubMed ID: 11927940
[TBL] [Abstract][Full Text] [Related]
33. Fas antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-gamma and tumor necrosis factor-alpha and potentiates apoptotic death.
Tsushima H; Imaizumi Y; Imanishi D; Fuchigami K; Tomonaga M
Exp Hematol; 1999 Mar; 27(3):433-40. PubMed ID: 10089905
[TBL] [Abstract][Full Text] [Related]
34. Fas ligand mRNA levels of circulating leukocytes reflect endothelial dysfunction in hyperlipidemic but not in non-hyperlipidemic patients.
Kotani N; Fukuo K; Yasuda O; Sugimoto K; Katuya T; Takemura Y; Kawamoto H; Yokoi T; Suzuki A; Ogihara T
Hypertens Res; 2006 Apr; 29(4):217-25. PubMed ID: 16778328
[TBL] [Abstract][Full Text] [Related]
35. Induction of Jurkat T-cell apoptosis by Fas ligand-transfected endothelial cells.
Cappellesso S; Thibault G; Hoarau C; Watier H; Bardos P; Lebranchu Y
Transplant Proc; 2000 Dec; 32(8):2737-8. PubMed ID: 11134778
[No Abstract] [Full Text] [Related]
36. Phenotypic and functional changes in blood monocytes following adherence to endothelium.
Tso C; Rye KA; Barter P
PLoS One; 2012; 7(5):e37091. PubMed ID: 22615904
[TBL] [Abstract][Full Text] [Related]
37. iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion.
Binion DG; Fu S; Ramanujam KS; Chai YC; Dweik RA; Drazba JA; Wade JG; Ziats NP; Erzurum SC; Wilson KT
Am J Physiol; 1998 Sep; 275(3):G592-603. PubMed ID: 9724273
[TBL] [Abstract][Full Text] [Related]
38. Cyclosporine enhances leukocyte adhesion to vascular endothelium under physiologic flow conditions.
Gallego MJ; Zoja C; Morigi M; Micheletti G; Imberti B; Foppolo M; Remuzzi A; Remuzzi G
Am J Kidney Dis; 1996 Jul; 28(1):23-31. PubMed ID: 8712218
[TBL] [Abstract][Full Text] [Related]
39. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma.
Choi C; Park JY; Lee J; Lim JH; Shin EC; Ahn YS; Kim CH; Kim SJ; Kim JD; Choi IS; Choi IH
J Immunol; 1999 Feb; 162(4):1889-95. PubMed ID: 9973455
[TBL] [Abstract][Full Text] [Related]
40. Oligotide anti-ischemic effect is related to in vitro inhibition of leukocyte-endothelial cell adhesion.
Pellegatta F; Ferrero E; Marni A; Chierchia S; Forti D; Ferrero ME
Transplant Proc; 1996 Feb; 28(1):339-41. PubMed ID: 8644250
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
